Showing results (401-410 of 513) with videos related to
Sort By:
Pageof 52
Journal of Pathology and Translational Medicine|March 27, 2018
Molecular Screening of Small Biopsy Samples Using Next-Generation Sequencing in Korean Patients with Advanced Non-small Cell Lung Cancer: Korean Lung Cancer Consortium (KLCC-13-01)Bo Mi Ku, Mi Hwa Heo, Joo-Hang Kim, et al.Japanese Journal of Clinical Oncology|February 11, 2004
Early concurrent chemoradiotherapy with prolonged oral etoposide and cisplatin for limited-stage small-cell lung cancerSe-Hoon Lee, Yong Chan Ahn, Ho Joong Kim, et al.The Annals of Thoracic Surgery|November 7, 2025
Clinical Characteristics and Surgical Outcomes of Patients Receiving Perioperative Pembrolizumab in KEYNOTE-671Moishe Liberman, David R Jones, Heather Wakelee, et al.Radiology|June 18, 2013
Differentiation of true progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide: comparison study of standard and high-b-value diffusion-weighted imagingHee Ho Chu, Seung Hong Choi, Inseon Ryoo, et al.Cancer|January 20, 2017
Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01)Youjin Kim, Su Jin Lee, Ji Yun Lee, et al.Histopathology|January 30, 2024
PD-L1 expression in resected lung adenocarcinoma: prevalence and prognostic significance in relation to the IASLC grading systemSoohyun Hwang, Tae Hee Hong, Hong Kwan Kim, et al.Endocrine-Related Cancer|July 15, 2026
Larotrectinib in TRK fusion differentiated thyroid carcinoma: updated trial dataSteven G Waguespack, Marcia S Brose, Jessica J Lin, et al.Lung Cancer (Amsterdam, Netherlands)|February 11, 2026
Amivantamab plus chemotherapy versus chemotherapy for first-line treatment of participants with EGFR exon 20 insertion-mutated advanced non-small cell lung cancer: PAPILLON Asia subgroup analysisCaicun Zhou, Ke-Jing Tang, Baogang Liu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 21, 2010
Expression of class III beta-tubulin correlates with unfavorable survival outcome in patients with resected non-small cell lung cancerYoungil Koh, Bogun Jang, Sae-Won Han, et al.Journal of Cancer Research and Clinical Oncology|December 18, 2015
Identification of genomic mutations associated with clinical outcomes of induction chemotherapy in patients with head and neck squamous cell carcinomaChan-Young Ock, Bongjun Son, Bhumsuk Keam, et al.Pageof 52